文献速递眼底病与葡萄膜炎

西尼罗病毒性葡萄膜炎的多中心研究:治疗、并发症与长期结局

A Multi-Institutional Study on West Nile Virus Uveitis: Treatment, Complications, and Long-Term Outcomes.
PubMed 文献 · Retina · 2026-09-30

急性期可见前房炎症、玻璃体炎症、黄斑囊样水肿及视网膜血管炎,部分需全身激素或免疫调节治疗,少数出现视网膜新生血管等并发症。

要点

  • 西尼罗病毒性葡萄膜炎可表现为前房炎症、玻璃体炎症、黄斑囊样水肿及视网膜血管炎。
  • 部分患者需全身激素或免疫调节治疗,复发性黄斑囊样水肿和视网膜血管炎可能需长期免疫调节。
  • 少数患眼可继发周边视网膜新生血管,需抗VEGF治疗或全视网膜激光光凝。

核心结论

  • 西尼罗病毒性葡萄膜炎常呈自限性病程,但部分患者病情顽固,黄斑囊样水肿和视网膜血管炎需全身免疫调节治疗实现长期控制。
  • 眼科医生应认识西尼罗病毒性葡萄膜炎较罕见的并发症,这些并发症可能需要干预。

研究设计与样本

  • 来自三家学术性葡萄膜炎诊所的回顾性观察研究。

主要发现

  • 平均患者为60岁白人(64%)女性(55%),27%患有糖尿病;55%就诊时Snellen视力为20/20至20/40。
  • 73%患者因脑炎或脑膜炎住院。
  • 急性表现包括前房炎症(8眼,36.4%)、玻璃体炎症(9眼,40.9%)、黄斑囊样水肿(6眼,27.3%)、非闭塞性视网膜血管炎(5眼,22.7%)和闭塞性视网膜血管炎(1眼,4.5%)。
  • 2眼(9.1%)继发周边视网膜新生血管,需抗血管内皮生长因子治疗或全视网膜激光光凝;8眼(36.4%)初始接受全身激素治疗,4眼(18.2%)因复发性黄斑囊样水肿和视网膜血管炎需免疫调节治疗。

临床怎么用

  • 对西尼罗病毒性葡萄膜炎患者应关注黄斑囊样水肿和视网膜血管炎的长期管理,必要时使用全身免疫调节治疗。
  • 需警惕继发周边视网膜新生血管等罕见并发症,及时进行抗VEGF治疗或全视网膜激光光凝。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: West Nile virus (WNV) can cause anterior/intermediate uveitis with characteristic multifocal chorioretinal lesions. Literature on acute manifestations is robust; however there is limited data describing the full spectrum of uveitic manifestations of WNV, treatments in the acute and chronic phase, as well as long-term sequelae. METHODS: A retrospective observational study from three academic uveitis practices. Patients diagnosed with WNV based on serologic and imaging findings were selected; data collected included demographics, ocular and systemic co-morbidities, ophthalmic examination findings, and treatment. RESULTS: Eleven patients were included between 2015 to 2023, with a mean follow-up of 128 weeks (∼ 2.5 years). The average patient was a 60-year-old Caucasian (64%) woman (55%); 27% of patients had diabetes. Fifty-five percent presented with 20/20-20/40 Snellen visual acuity. Importantly, 73% of patients in this cohort were hospitalized due to encephalitis or meningitis. Acute findings included anterior inflammation (8 [36.4%] eyes), vitreous inflammation (9 [40.9%] eyes), cystoid macular edema (CME) (6 [27.3%] eyes), non-occlusive retinal vasculitis (5 [22.7%]), and 1 (4.5%) eye with occlusive retinal vasculitis. Two (9.1%) eyes developed secondary peripheral retinal neovascularization requiring anti-vascular endothelial growth factor treatment or laser panretinal photocoagulation. Eight (36.4%) eyes were initially treated with systemic steroids, and 4 (18.2%) eyes required immunomodulatory therapy (IMT) for recurrent CME and retinal vasculitis. CONCLUSION: WNV uveitis often has a self-limited course but can be intractable in some patients, with long-term control needed for CME and retinal vasculitis with systemic IMT. Ophthalmologists must be aware of the rarer complications that may require intervention.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Begaj T, Tauqeer Z, Liu R, et al. A Multi-Institutional Study on West Nile Virus Uveitis: Treatment, Complications, and Long-Term Outcomes. Retina. 2026. PMID: 42814007. doi:10.1097/IAE.0000000000005025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。